Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma

Por Guan, Z, Wang, Y, Maoleekoonpairoj, S, Chen, Z, Kim, W S, Ratanatharathorn, V, Reece, W H H, Kim, T W, Lehnert, M
Publicado em 2003

Naturally Exposed Populations Differ in Their T1 and T2 Responses to the Circumsporozoite Protein of Plasmodium falciparum

Por Reece, W. H. H., Plebanski, M., Akinwunmi, P., Gothard, P., Flanagan, K. L., Lee, E. A. M., Cortina-Borja, M., Hill, A. V. S., Pinder, M.
Publicado em 2002

Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia

Por PINDER, M, REECE, W H H, PLEBANSKI, M, AKINWUNMI, P, FLANAGAN, K L, LEE, E A M, DOHERTY, T, MILLIGAN, P, JAYE, A, TORNIEPORTH, N, BALLOU, R, MCADAM, K P M J, COHEN, J, HILL, A V S
Publicado em 2004